ML21011A237

From kanterella
Revision as of 12:11, 14 March 2021 by StriderTol (talk | contribs) (StriderTol Bot insert)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Shine Medical Technologies, LLC - Operating License Application Supplement No. 6 and Response to Request for Additional Information - Final Safety Analysis Report Change of Summary
ML21011A237
Person / Time
Site: SHINE Medical Technologies
Issue date: 12/15/2020
From:
SHINE Medical Technologies
To:
Office of Nuclear Reactor Regulation
References
2020-SMT-0131
Download: ML21011A237 (1)


Text

ENCLOSURE 1 SHINE MEDICAL TECHNOLOGIES, LLC SHINE MEDICAL TECHNOLOGIES, LLC OPERATING LICENSE APPLICATION SUPPLEMENT NO. 6 AND RESPONSE TO REQUEST FOR ADDITIONAL INFORMATION FINAL SAFETY ANALYSIS REPORT CHANGE

SUMMARY

Summary Description of Changes FSAR Impacts Administrative corrections including clarification of the Section 8a2.2, Table 8a2.2-2, aging factor applied for battery sizing and correction of the Section 8a2.3 revision year for a referenced industry standard.

Update to incorporate normal electric power supply Section 8a2.1, Figure 8a2.1-1, system (NPSS) design changes including changes to the Section 8a2.2 off-site power service supplies as well as changes to the on-site distribution service design.

Update to incorporate uninterruptable electrical power Section 8a2.2, Table 8a2.2-1, supply system (UPSS) design changes including updates Table 8a2.2-2 to UPSS electrical loading to include data from equipment vendor specifications and UPSS load list calculation updates.

Final Safety Analysis Report (FSAR) mark-ups related to the SHINE Medical Technologies, LLC (SHINE) responses to requests for additional information are provided as Attachment 1 to (non-public version) and Enclosure 3 (public version). FSAR mark-ups associated with the above FSAR changes are included with those mark-ups provided as Attachment 1 to and Enclosure 3.

Page 1 of 1